2 completed, 1 recruiting. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Migraine, With or Without Aura: new trials by email Literature Review of Migraine, With or Without Aura trials Research Report on Migraine, With or Without Aura
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults BR005-036C, Placebo - Migraine, With or Without Aura | Phase 2 / Phase 3 | Recruiting | Brise Pharmaceuticals Co., Ltd. | 2079 | 2026-09-30 | 2026-10-23 |
| Open Label Safety Study in Acute Treatment of Migraine Rimegepant - Migraine, With or Without Aura | Phase 2 / Phase 3 | Completed | Pfizer | 3019 | 2017-08-30 | 2023-02-16 |
| Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention Atogepant, Placebo-matching Atogepant - Migraine, With or Without Aura | Phase 2 / Phase 3 | Completed | Allergan | 834 | 2016-09-06 | 2018-12-06 |
Brain Diseases (3) · Central Nervous System Diseases (3) · Headache Disorders (3) · Headache Disorders, Primary (3) · Nervous System Diseases (3)
atogepant (1) · rimegepant sulfate (1)
Allergan (1) · Brise Pharmaceuticals Co., Ltd. (1) · Pfizer (1)
United States (2) · China (1)
Joel Trugman, MD (1)
PMID 31932515, PMID 32822633, PMID 34455556, PMID 35038983, PMID 38462625, PMID 38659334, PMID 38764606, PMID 38985436, PMID 39520634, PMID 39648629, PMID 39982105, PMID 40629887